Drugs Made In America Acquisition (DMAA) Operating Expenses (2025)
Drugs Made In America Acquisition (DMAA) reported Operating Expenses of $2.1 million for Q4 2025, up 692.36% quarter-over-quarter from $263703.0 in Q3 2025.
Drugs Made In America Acquisition (DMAA) Operating Expenses (2025) Analysis & Trends
Drugs Made In America Acquisition has reported Operating Expenses for 1 years, with the latest figure at $2.1 million in Q4 2025.
- For the quarter ending Q4 2025, Operating Expenses changed N/A year-over-year to $2.1 million; the trailing twelve-month figure through Dec 2025 stood at $2.8 million (changed N/A YoY), and the FY2025 full-year result was $2.8 million, up 906.28% from the prior year.
- Operating Expenses for Q4 2025 stood at $2.1 million, up from $263703.0 in the prior quarter.
- The five-year high for Operating Expenses was $2.1 million in Q4 2025, with the low at $131919.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 427,850.00 |
| 2 | Berto Acquisition | 312.46 Mn | 312.46 Mn | - | 482,100.00 |
| 3 | Centurion Acquisition | 311.65 Mn | 311.65 Mn | - | 201,744.00 |
| 4 | GP-Act III Acquisition | 311.36 Mn | 311.36 Mn | - | 84,204.00 |
| 5 | Churchill Capital Corp IX | 310.79 Mn | 310.79 Mn | - | 1.15 Mn |
| 6 | WEN Acquisition | 309.15 Mn | 309.15 Mn | - | 225,545.00 |
| 7 | Bold Eagle Acquisition | 275.54 Mn | 275.54 Mn | - | 198,194.00 |
| 8 | Soulpower Acquisition | 264.91 Mn | 264.91 Mn | - | 685,558.00 |
| 9 | BTC Development | 262.16 Mn | 262.16 Mn | - | 540,761.00 |
| 10 | Drugs Made In America Acquisition | 223.11 Mn | 223.11 Mn | - | 2.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.09 Mn |
| Sep 30, 2025 | 263,703.00 |
| Jun 30, 2025 | 131,919.00 |
| Mar 31, 2025 | 330,925.00 |